Current Opinion in Neurology

Papers
(The TQCC of Current Opinion in Neurology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation74
Management of neuropsychiatric symptoms in dementia63
Update on management of cerebral venous thrombosis60
The recent surge of functional movement disorders: social distress or greater awareness?52
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis49
Assessing treatment response in multiple sclerosis49
From basic mechanisms to therapeutic perspectives in cluster headache47
Editorial introductions47
The 2021 WHO classification of central nervous system tumors: what neurologists need to know44
Microglia in multiple sclerosis – pathogenesis and imaging40
Neuro-oncology is moving quickly toward new horizons of diagnosis and treatment38
Hereditary motor neuropathies37
The role of the gut microbiome in Alzheimer's disease pathophysiology36
Neurosyphilis in 2025: Erratum35
Neurology education in the era of artificial intelligence35
Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population34
Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond30
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies28
Historical development and contemporary use of neuromodulation in human spinal cord injury28
Updates in neuro-otology27
Central nervous system adverse events of immune checkpoint inhibitors27
Editorial introductions27
Gene therapies for CMT neuropathies: from the bench to the clinic27
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection26
Editorial: Epilepsy advances in 202326
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial25
Multiple sclerosis in China: the current state of diagnosis and management25
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise24
Connecting tremors – a circuits perspective24
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management23
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke23
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery23
Update on the clinical and therapeutic aspects of myotonic dystrophy type 122
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms22
Threat of resurgence or hope for global eradication of poliovirus?21
Thymectomy in myasthenia gravis21
Migraine in women: a review21
Global to individual: key domains of burden in pediatric headache21
The FSHD jigsaw: are we placing the tiles in the right position?21
Clinical impact of molecular profiling in rare brain tumors20
Levodopa infusion therapies for Parkinson disease20
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment20
Nerve ultrasound in the diagnosis of inflammatory neuropathies20
fMRI-based spatio-temporal parcellations of the human brain19
Diet and migraine: what is proven?19
MRI for the diagnosis of limb girdle muscular dystrophies19
Red flags in multiple sclerosis19
Gauging and controlling excitability in cortical disorders18
MRI in multiple sclerosis: progress in in-vivo pathobiology18
Novel pharmacological therapies in development18
Obesity-related neuropathy: the new epidemic18
Acute stroke care in low and middle-income countries18
Update on dermatomyositis18
Electrical stimulation of the peripheral and central vestibular system18
Parkinson's disease – genetic cause17
Targeting IDH1/IDH2 mutations in gliomas17
Editorial: The gap between academic advances and therapy development in motor neuron disease17
Idiopathic intracranial hypertension: expanding our understanding17
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications16
Recent advances in Alzheimer disease genetics16
Neuroinflammation and immunometabolism in neurodegenerative diseases16
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis16
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers16
Autoimmune encephalitis and paraneoplastic neurologic syndrome: clinical diagnosis16
Editorial introductions16
Optic neuritis: current challenges in diagnosis and management16
Progress in spinal muscular atrophy research16
Novel approaches to treatment of leptomeningeal metastases16
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond15
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management15
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies15
The state of art on the use of patient reported outcomes in migraine15
Sex and gender differences in neurological infections15
New developments in diagnostics and treatment of adult-onset focal dystonia15
Monitoring multiple sclerosis: digital and fluid phase biomarkers15
Neurosyphilis in 202515
Update on genetics of amyotrophic lateral sclerosis14
Abnormal energy metabolism in ALS: a key player?14
Recent insights in striated muscle laminopathies14
Fluid phase biomarkers in multiple sclerosis14
The monoaminergic systems as drivers of Alzheimer's disease pathophysiology and symptomatology14
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health14
Diagnosing viral encephalitis and emerging concepts14
PET imaging of microglial pathology in multiple sclerosis13
Imaging of vestibular function and disorders and its clinical relevance13
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum13
Update on modifiable risk factors for Alzheimer's disease and related dementias13
Current trend in air pollution exposure and stroke13
Converging perspectives in vestibular neurology13
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders13
New insights in the immune treatment of Guillain–Barré syndrome13
Precision medicine in Moyamoya vasculopathy13
Editorial introductions13
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease13
Imaging cortical lesions in multiple sclerosis13
Immune checkpoint inhibitors induced side effects of the peripheral nervous system12
Peripheral visual field loss and activities of daily living12
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy12
Vestibular migraine. Clinical and diagnostic challenges, and emerging therapeutic approaches12
Current gaps in acute reperfusion therapies12
Editorial: Seizure disorders: 2023 update12
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review11
Progress in treatment of gliomas11
Editorial: Cerebrovascular disease11
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury11
Muscle ultrasound in myopathies11
Long COVID and especially headache syndromes11
Nonneurologic causes of binocular diplopia for the neurologist11
Update on functional vestibular and gait disorders11
Genetic role in autoimmune encephalitis and paraneoplastic neurological syndromes11
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients11
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period11
Multiple sclerosis: advances and challenges in diagnosis11
0.23493814468384